WASHINGTON, Dec 16 (Reuters) - Two U.S. lawmakers are
questioning whether Heritage Pharmaceuticals misled them in
response to a 2014 congressional inquiry about the rising price
a common antibiotic, after 20 U.S. states this week accused the
company of price fixing.
Read more
No comments:
Post a Comment